Stock Events

Stock Events

Amphastar Pharmaceuticals (29A.F) Q2 2025 Earnings

7MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

0.61

0.71

0.81

0.91

Details

Expected EPS

0.60713036139

Actual EPS

0.6542858

Surprise EPS

0.05

Surprise Percent

+7.77%

Description

Amphastar Pharmaceuticals (29A.F) has reported earnings of 0.6542858 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.